AQST Aquestive Therapeutics
- 4.070
- +0.140+3.56%
- 3.970
- -0.100-2.46%
Aquestive Therapeutics News
Aquestive Wins FDA Approval for Anti-seizure Therapy Libervant
Express News | FDA Approves Aquestive Therapeutics' Libervant- Website
Express News | Aquestive Therapeutics Dips Amid Volume Spike, Last Down 6.0%
OPI, RVNC and AQST Are Among After Hour Movers
Ally Financial Reports Upbeat Earnings, Joins Badger Meter, Genuine Parts And Other Big Stocks Moving Higher On Thursday
U.S. stocks were lower, with the Nasdaq Composite falling over 50 points on Thursday.Shares of Ally Financial Inc. (NYSE:ALLY) rose sharply during Thursday's session after the company reported better-
Express News | Aquestive Therapeutics To Present Crossover Study Data For Libervant Buccal Film At 76th Annual Meeting Of American Academy Of Neurology
Aquestive Therapeutics to Present Crossover Study Data for Libervant (Diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology
Aquestive Therapeutics, Inc. (NASDAQ: AQST) today announced a poster presentation highlighting the crossover study for the Company's product candidate, Libervant (diazepam) Buccal Film for treatment of children with epilepsy aged two to five, will be presented at the 76th Annual Meeting of the American Academy of Neurology (AAN) in Denver from April 13 to 18, offering both in-person attendance and live online participation in a hybrid format.
Aquestive Therapeutics a New Overweight at Piper on Oral Film Products
Piper Starts Aquestive at Overweight, Cites Allergy Reaction Treatment
Aquestive Therapeutics Initiated at Overweight by Piper Sandler
Aquestive Therapeutics Initiated at Overweight by Piper Sandler
Aquestive Therapeutics Price Target Announced at $10.00/Share by Piper Sandler
Aquestive Therapeutics Price Target Announced at $10.00/Share by Piper Sandler
Express News | Piper Sandler Initiates Coverage On Aquestive Therapeutics With Overweight Rating, Announces Price Target of $10
Analysts Offer Insights on Healthcare Companies: EFFECTOR Therapeutics (EFTR), Adagene (ADAG) and Aquestive Therapeutics (AQST)
Express News | HC Wainwright & Co. Reiterates Buy on Aquestive Therapeutics, Maintains $9 Price Target
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of STAAR Surgical Company (NASDAQ:STAA) rose sharply during Thursday's session after the company issued strong preliminary first-quarter net sales guidance. STAAR Surgical shares jumped 13.3%
Lamb Weston Reports Weak Earnings, Joins Paragon 28, Resources Connection And Other Big Stocks Moving Lower On Thursday
U.S. stocks were higher, with the Dow Jones gaining over 150 points on Thursday. Shares of Lamb Weston Holdings, Inc. (NYSE:LW) fell sharply during Thursday's session after the company reported weak
Express News | Aquestive Therapeutics Shares Are Trading Lower After the Company Filed for an up to $250 Million Mixed Shelf Offering
Aquestive Therapeutics Files for $250M Mixed Securities Shelf
Aquestive Therapeutics (AQST) Ascends While Market Falls: Some Facts to Note
Aquestive Therapeutics Appoints Abigail Jenkins to the Company's Bd of Directors >AQST
Aquestive Therapeutics Appoints Abigail Jenkins to the Company's Bd of Directors >AQST
Analysis
Price Target
No Data
